Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 2
1979 3
1981 1
1982 4
1983 3
1985 1
1986 1
1987 5
1988 1
1989 5
1990 5
1991 2
1992 4
1993 1
1994 5
1996 7
1997 4
1998 4
1999 4
2000 6
2001 5
2002 5
2003 4
2004 8
2005 4
2006 9
2007 8
2008 6
2009 7
2010 5
2011 2
2012 3
2013 4
2014 6
2015 7
2016 7
2017 10
2018 25
2019 15
2020 17
2021 24
2022 20
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year

Filters applied: . Clear all
Page 1
Approach to patients with pseudo-Cushing's states.
Scaroni C, Albiger NM, Palmieri S, Iacuaniello D, Graziadio C, Damiani L, Zilio M, Stigliano A, Colao A, Pivonello R; Altogether to Beat Cushing’s Syndrome (ABC) study group. Scaroni C, et al. Among authors: palmieri s. Endocr Connect. 2020 Jan;9(1):R1-R13. doi: 10.1530/EC-19-0435. Endocr Connect. 2020. PMID: 31846432 Free PMC article. Review.
Postpartum urinary retention: Absolute risk prediction model.
Barba M, Frigerio M, Manodoro S, Bernasconi DP, Cola A, Palmieri S, Fumagalli S, Vergani P. Barba M, et al. Among authors: palmieri s. Low Urin Tract Symptoms. 2021 Apr;13(2):257-263. doi: 10.1111/luts.12362. Epub 2020 Oct 28. Low Urin Tract Symptoms. 2021. PMID: 33118328
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.
Bertamini L, Oliva S, Rota-Scalabrini D, Paris L, Morè S, Corradini P, Ledda A, Gentile M, De Sabbata G, Pietrantuono G, Pascarella A, Tosi P, Curci P, Gilestro M, Capra A, Galieni P, Pisani F, Annibali O, Monaco F, Liberati AM, Palmieri S, Luppi M, Zambello R, Fazio F, Belotti A, Tacchetti P, Musto P, Boccadoro M, Gay F. Bertamini L, et al. Among authors: palmieri s. J Clin Oncol. 2022 Sep 20;40(27):3120-3131. doi: 10.1200/JCO.21.01393. Epub 2022 Jun 6. J Clin Oncol. 2022. PMID: 35666982
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials.
Bruzzese A, Derudas D, Galli M, Martino EA, Rocco S, Conticello C, Califano C, Giuliani N, Mangiacavalli S, Farina G, Lombardo A, Brunori M, Rossi E, Antonioli E, Ria R, Zambello R, Di Renzo N, Mele G, Marcacci G, Pietrantuono G, Palumbo G, Cascavilla N, Cerchione C, Belotti A, Criscuolo C, Uccello G, Curci P, Vigna E, Mendicino F, Iaccino E, Mimmi S, Botta C, Vincelli D, Sgherza N, Bonalumi A, Cupelli L, Stocchi R, Martino M, Ballanti S, Gangemi D, Gagliardi A, Gamberi B, Pompa A, Tripepi G, Frigeri F, Consoli U, Bringhen S, Zamagni E, Patriarca F, De Stefano V, Di Raimondo F, Palmieri S, Petrucci MT, Offidani M, Musto P, Boccadoro M, Cavo M, Neri A, Morabito F, Gentile M. Bruzzese A, et al. Among authors: palmieri s. Hematol Oncol. 2022 Oct;40(4):704-715. doi: 10.1002/hon.3031. Epub 2022 Jun 1. Hematol Oncol. 2022. PMID: 35608183 Free article.
Non classical complications of primary hyperparathyroidism.
Chiodini I, Cairoli E, Palmieri S, Pepe J, Walker MD. Chiodini I, et al. Among authors: palmieri s. Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):805-820. doi: 10.1016/j.beem.2018.06.006. Epub 2018 Jun 18. Best Pract Res Clin Endocrinol Metab. 2018. PMID: 30665548 Review.
243 results